Page last updated: 2024-10-31

midodrine and Long QT Syndrome

midodrine has been researched along with Long QT Syndrome in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dubin, AM1
Van Hare, GF1

Reviews

1 review available for midodrine and Long QT Syndrome

ArticleYear
Advances in the treatment of cardiac rhythm disturbances.
    Current opinion in pediatrics, 1999, Volume: 11, Issue:5

    Topics: Adrenergic alpha-Agonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cisapride; Electrophysiolog

1999